跳至主要内容
临床试验/JPRN-UMIN000004150
JPRN-UMIN000004150已完成未知

The effect of remifentanil on cardiac conduction system in pediatric patients undergoing radiofrequency catheter ablation - The effect of remifentanil on cardiac conduction system in pediatric patients undergoing radiofrequency catheter ablation

Department of Anesthesiology Japanese Red Cross Society Wakayama Medical Center0 个研究点目标入组 60 人开始时间: 2010年9月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3years-old 至 16years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria 1) obesity 2) allergy to the trial or companion drugs 3) previous history of kidney, and/or liver disease. 4) patients with severe heart diseases including cardiomyopathy, valvulopathy, and congenital cardiac diseases 5) patients deemed unsuitable for the study by investigators

研究者

发起方
Department of Anesthesiology Japanese Red Cross Society Wakayama Medical Center

相似试验